Human Genome Sciences (NASDAQ: HGSI) is a biopharmaceutical corporation founded in 1992. It uses the human DNA sequence to develop protein and antibody drugs. As of 2008, it has drugs under development to treat such diseases as hepatitis C, systemic lupus erythmatosis, anthrax disease, and cancer. It collaborates with other biotechnology and pharmaceutical companies, for development partnerships and licensing.
On July 16, 2012, HGS agreed to be purchased by GlaxoSmithKline for $3.6 billion.
Read more about Human Genome Sciences: Corporate History, Collaboration With Cambridge Antibody Technology, Pipeline, Bibliography
Famous quotes containing the words human and/or sciences:
“The mimes become its food,
And seraphs sob at vermin fangs
In human gore imbued.”
—Edgar Allan Poe (1809–1849)
“All cultural change reduces itself to a difference of categories. All revolutions, whether in the sciences or world history, occur merely because spirit has changed its categories in order to understand and examine what belongs to it, in order to possess and grasp itself in a truer, deeper, more intimate and unified manner.”
—Georg Wilhelm Friedrich Hegel (1770–1831)